UPO Book

Brief Research Description

Clinical and translational research program focused on therapeutic innovation and patient individualisation in breast cancer. centering on the early clinical implementation of innovative experimental anticancer therapies to the clinic, with specific accent on anti-cancer immunotherapy.

Study of predictive factors host and tumor related in breast cancer.

Role of molecular imaging with conventional (18F-FDG) and experimental (18F-FES) radiotracer in early and advanced breast cancer

Novel prognostic and predictive biomarkers in early breast cancer.

Pathology of host and tumor related feature: immune phenotyping of PBMC in triple negative breast cancer.

The role of innate and adaptive immunity as a prognostic marker and therapeutic monitoring of breast cancer.

Primary and metastatic braest cancer: identification of host related signatures with predictive impact including metabolomics and lipidomics.

Keywords

Translational research, breast cancer, immunotherapy, clinical trials,

biomarkers, host metabolism, molecular imaging

PubMed